1989
DOI: 10.1007/bf03005343
|View full text |Cite
|
Sign up to set email alerts
|

Anaesthesia for abdominal aortic surgery — a review (Part I)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1991
1991
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 127 publications
0
7
0
Order By: Relevance
“…The magnitude of the cardiovascular response to AXC is dependent on the actual site of the clamp (25). Following thoracic AXC, 40% increases in SVR and up to 60% increases in proximal MAP have been reported (3). Infra-renal AXC is associated with less pronounced responses and 15-30% increases in proximal MAP have been demonstrated (4,5).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The magnitude of the cardiovascular response to AXC is dependent on the actual site of the clamp (25). Following thoracic AXC, 40% increases in SVR and up to 60% increases in proximal MAP have been reported (3). Infra-renal AXC is associated with less pronounced responses and 15-30% increases in proximal MAP have been demonstrated (4,5).…”
Section: Discussionmentioning
confidence: 99%
“…In the circulation proximal to the clamp , AXC is usually associated with increases in arterial blood pressure and systemic vascular resistance and moderate reductions in stroke volume and cardiac output (1)(2)(3)(4). The effects of AXC on pulmonary arterial occlusion pressure and central venous pressure seem to depend on whether ischaemic heart disease is present or not (5).…”
mentioning
confidence: 99%
“…Other options for these patients include serial three-monthly observations with abdominal ultrasound or internal iliac ligation with axillobifemoral bypass. 50 Besides CAD, the preoperative evaluation…”
Section: Preoperative Evaluation and Preparationmentioning
confidence: 99%
“…Nonetheless, tachycardia associated with dopexamine infusion is a concern in a patient population with a high incidence of overt and covert ischaemic heart disease. 6 Dopexamine hydrochloride is a synthetic dopaminergic (DA-1) and beta-2 adrenoreceptor agonist. As such, it has been reported to be one third as potent as dopamine in stimulating DA-1 receptors but 60 times more potent as a beta-2 adrenoceptor agonist.…”
Section: Group I Group Ii Normal Meanmentioning
confidence: 99%